22
Feb
Posted by admin as Drug Facts
|
|
World’s leading meds delivered to your door – and you don’t even need a
prescription! Only certified, first class drugs on offer! Buy more and spend
less with our great discount system.
The only pharmacy shop you will ever need! Approved drugs available without
prescription. Best deals, unmatched service and shipping. 100% safe!
|
| (meth-oh-CAR-buh-mahl) |
| Robaxin, Robaxin Injectable, Robaxin-750 |
| Class: Skeletal muscle relaxant/centrally acting |
Action May cause relaxation of skeletal muscle via general CNS depression. Does not directly relax tense skeletal muscles.
Indications Adjunctive therapy for relief of painful, acute musculoskeletal conditions; ontrol of neuromuscular manifestations of tetanus.
Contraindications Renal pathologic disorders (parenteral form).
Route/Dosage
Skeletal Muscle Relaxation
ADULTS: Initial dose: IV/IM 3 g over £ 3 consecutive days. Repeat course after 48 hr lapse if condition persists. PO 1.5 g qid. MAINTENANCE: PO 1 g qid or 750 mg q 4 hr, or 1.5 g tid. For first 48–72 hr, 6–8 g/day is recommended; then reduce to 4 g/day.
Tetanus
ADULTS: IV 1–2 g; additional 1–2 g may be added to infusion up to 3 g total. Repeat q 6 hr until oral form may be administered. CHILDREN: IV/IV infusion 15 mg/kg initially; then 15 mg/kg q 6 hr.
Interactions None well documented.
Lab Test Interferences Screening tests for 5-hydroxy-indoleacetic acid or vanillylmandelic acid: Drug may cause color interference.
Adverse Reactions
CV: Syncope; hypotension; bradycardia. CNS: Dizziness; lightheadedness; vertigo; headache; drowsiness; fainting; ild muscular incoordination; convulsions in epileptic patients. DERM: Urticaria; pruritus; rash; flushing. EENT: Blurred vision; conjunctivitis with nasal congestion; nystagmus; diplopia; etallic taste. GI: GI upset; nausea. OTHER: Thrombophlebitis; pain or sloughing at injection site; anaphylactic reaction; fever.
Precautions
Pregnancy: Safety not established. Avoid use, if possible. Lactation: Undetermined. Children: Safety and efficacy in children < 12 yr not established, except for management of tetanus.
| PATIENT CARE CONSIDERATIONS |
|
Administration/Storage
- Administer parenteral form for no more than 3 days.
- Wait 48 hr before repeating with additional course if needed.
- For parenteral administration, do not administer SC; drug should be given IV or IM.
- Assess patency of IV site prior to administration; if patency is in doubt, start new IV to avoid extravasation.
- Administer via slow IV push or as infusion.
- Infuse in solution of D5W or saline solution £ 1 vial/250 ml.
- Keep prepared infusion at room temperature.
- For IV administration, place patient in recumbent position; ave patient remain recumbent for 10–15 min after administration to prevent orthostatic hypotension.
- Monitor vital signs and IV flow rate.
- For IM administration, inject deeply and do not exceed 5 ml in each gluteal area. Rotate injection sites.
- For oral administration, administer loading dose followed by maintenance dose.
- May crush tablets if necessary.
- Administer with food to decrease stomach upset.
- Store at room temperature.
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note epilepsy and renal pathologic conditions.
- Perform physical assessment noting muscle tone, range of motion, pain, CNS function, mentation and vital signs.
- Observe IV site for phlebitis.
- Provide safe environment (eg, keep bed in low position with side rails up, instruct patient to call for assistance when rising).
- Move patient slowly from recumbent to sitting or standing position.
- Keep oxygen and epinephrine available in event of anaphylaxis.
- Monitor for effectiveness of drug and side effects, especially dizziness, drowsiness, rash, pruritus, fever and congestion.
- If patient experiences syncope, place in reverse Trendelenburg’s position and monitor vital signs.
- Notify physician if patient does not spontaneously recover.
- Notify physician if extravasation occurs.
| OVERDOSAGE: SIGNS & SYMPTOMS |
| |
Coma, CNS depression |
|
Patient/Family Education
- Instruct patient regarding additional therapy recommended to treat muscle spasm such as activity restrictions or physical therapy.
- Advise patient that drug may cause drowsiness, dizziness and lightheadedness and to use caution while driving or performing other tasks requiring mental alertness.
- Caution patient not to discontinue medication abruptly without consulting physician.
- Inform patient that urine may become different or darker color.
- Instruct patient to report these symptoms to physician: skin rash, itching, fever or nasal congestion.
- Caution patient to avoid sudden changes in position to prevent orthostatic hypotension.
- Instruct patient to avoid intake of alcoholic beverages or other CNS depressants.
- Advise patient not to take otc medications without consulting physician.
Popularity: 35% [?]
If you're still unable to find appropriate information in the article, please use search form below
RSS feed for comments on this post · TrackBack URI
Leave a reply